We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+28.42%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$410M
AUM Growth
-$13.6M
Cap. Flow
-$91.9M
Cap. Flow %
-22.4%
Top 10 Hldgs %
19.75%
Holding
160
New
36
Increased
28
Reduced
53
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 27.13%
2 Industrials 24.98%
3 Healthcare 17.1%
4 Consumer Discretionary 13.96%
5 Consumer Staples 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRBR icon
51
BellRing Brands
BRBR
$1.37B
$3.75M 0.91%
63,510
+2,990
+5% +$170K
ITCI
52
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.69M 0.9%
53,285
+400
+0.8% +$27.5K
NXT icon
53
Nextpower Inc
NXT
$15.4B
$3.67M 0.9%
65,300
-13,600
-17% -$724K
HLIT icon
54
Harmonic Inc
HLIT
$1.29B
$3.66M 0.89%
+272,245
New +$3.47M
VSEC icon
55
VSE Corp
VSEC
$6.06B
$3.57M 0.87%
+44,570
New +$3.04M
SG icon
56
Sweetgreen
SG
$638M
$3.55M 0.87%
+140,700
New +$2.05M
ARCB icon
57
ArcBest
ARCB
$3.07B
$3.52M 0.86%
+24,730
New +$3.24M
CAMT icon
58
Camtek
CAMT
$7.31B
$3.5M 0.85%
41,760
-32,080
-43% -$2.52M
INSP icon
59
Inspire Medical Systems
INSP
$1.72B
$3.34M 0.81%
15,530
+4,050
+35% +$794K
ALKT icon
60
Alkami Technology
ALKT
$2.08B
$3.32M 0.81%
+134,955
New +$3.31M
CRNX icon
61
Crinetics Pharmaceuticals
CRNX
$8.9B
$3.24M 0.79%
69,225
-31,020
-31% -$1.21M
CVLT icon
62
Commault Systems
CVLT
$5.65B
$3.16M 0.77%
+31,175
New +$2.82M
MGNI icon
63
Magnite
MGNI
$3.61B
$3.06M 0.75%
+284,930
New +$2.85M
BOOT icon
64
Boot Barn
BOOT
$4.91B
$3.06M 0.74%
+32,110
New +$2.65M
CVNA icon
65
Carvana
CVNA
$79.5B
$3.04M 0.74%
+172,850
New +$2.11M
SLAB icon
66
Silicon Laboratories
SLAB
$7.23B
$2.97M 0.72%
+20,695
New +$2.74M
ITRI icon
67
Itron
ITRI
$4.5B
$2.97M 0.72%
+32,090
New +$2.58M
FCFS icon
68
FirstCash
FCFS
$8.9B
$2.87M 0.7%
22,485
-625
-3% -$72.4K
SPT icon
69
Sprout Social
SPT
$611M
$2.74M 0.67%
45,925
-56,730
-55% -$3.45M
DYN icon
70
Dyne Therapeutics
DYN
$4.74B
$2.46M 0.6%
+86,610
New +$1.96M
BRZE icon
71
Braze
BRZE
$2.97B
$2.39M 0.58%
+54,060
New +$2.92M
RRR icon
72
Red Rock Resorts
RRR
$3.64B
$2.26M 0.55%
+37,785
New +$2.1M
ANIP icon
73
ANI Pharmaceuticals
ANIP
$1.77B
$2.22M 0.54%
+32,085
New +$1.94M
AVDX
74
DELISTED
AvidXchange
AVDX
$2.21M 0.54%
167,715
+61,795
+58% +$742K
CAVA icon
75
CAVA Group
CAVA
$7.41B
$2.2M 0.54%
31,455
-34,435
-52% -$1.85M

Similar funds

Lisanti Capital Growth's Q1 2024 Portfolio in Review

As of Q1 2024, Lisanti Capital Growth held 160 positions worth $410M, down 3.2% from $424M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth withdrew a net $91.9M in Q1 2024, closing 43 positions and reducing 53 holdings. Its most notable exit was Pinnacle Financial Partners Inc, an estimated $7.78M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in TechnipFMC worth $7M.

  • Lisanti Capital Growth's largest Q1 2024 buy was TechnipFMC: 278,625 shares worth $7M.
  • Lisanti Capital Growth added most to Credo Technology Group in Q1 2024, an estimated $5.08M increase.
  • Lisanti Capital Growth's biggest Q1 2024 reduction was Viking Therapeutics, cutting an estimated $13.1M.
  • Lisanti Capital Growth fully exited Pinnacle Financial Partners Inc in Q1 2024, selling an estimated $7.78M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $410M portfolio in Q1 2024.
  • Lisanti Capital Growth opened 36 new positions and closed 43 in Q1 2024.
  • Lisanti Capital Growth's portfolio value fell 3.2% quarter-over-quarter to $410M.

Based on Lisanti Capital Growth's 13F filing for Q1 2024, filed 7 May 2024.